Detalhe da pesquisa
1.
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE study.
Acta Oncol
; 62(12): 1742-1748, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738268
2.
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.
Br J Cancer
; 127(3): 500-513, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440666
3.
Perioperative changes in cell-free DNA for patients undergoing surgery for colon cancer.
BMC Gastroenterol
; 22(1): 168, 2022 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387596
4.
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer.
Int J Cancer
; 149(6): 1385-1397, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961700
5.
Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
Br J Haematol
; 194(1): 53-60, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114218
6.
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population.
Blood
; 134(5): 469-479, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217187
7.
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer.
Cancer Immunol Immunother
; 69(2): 315-324, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915854
8.
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Haematologica
; 105(9): 2262-2272, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054051
9.
Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer.
Acta Oncol
; 59(12): 1424-1429, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790489
10.
International external quality assurance of JAK2 V617F quantification.
Ann Hematol
; 98(5): 1111-1118, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535576
11.
Bridging blood cancers and inflammation: The reduced Cancitis model.
J Theor Biol
; 465: 90-108, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615883
12.
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Eur J Haematol
; 103(1): 26-34, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985947
13.
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer.
Tumour Biol
; 40(11): 1010428318811207, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486767
14.
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs.
Ann Hematol
; 97(12): 2299-2308, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30056580
15.
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Haematologica
; 107(8): 1971-1976, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484650
16.
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol.
Acta Oncol
; 61(9): 1152-1156, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094310
17.
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.
Gut
; 65(4): 625-34, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25654990
18.
Molecular diagnostics of myeloproliferative neoplasms.
Eur J Haematol
; 95(4): 270-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25951317
19.
Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.
Int J Cancer
; 135(9): 2215-22, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659028
20.
Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
Int J Cancer
; 135(12): 2984-91, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24798213